Risk for HIV-1 infection is not associated with Repeat-Region polymorphism in the DC-SIGN neck domain and Novel Genetic DC-SIGN Variants among North Indians

Clinica Chimica Acta

Volumn 391, Issue 1-2, 2008, Pages 1-5

  Rathore, Anurag ^a   Chatterjee, Animesh ^a   Sood, Vikas ^b   Khan, Sohrab Z ^b   Banerjea, Akhil C ^b   Yamamoto, Naohiko ^c   Dhole, Tapan N ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DC SIGN; DC SIGN gene; Exon; HIV 1 infection; Innate immunity; Intron

Indexed keywords

CD209 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; ALLELES; BASE SEQUENCE; CELL ADHESION MOLECULES; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; LECTINS, C-TYPE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; SEQUENCE ALIGNMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 41849110520     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.019     Document Type: Article

References (14)

1. O'Brien S.J., and Nelson G.W. Human genes that limit AIDS. Nat Genet 36 6 (2004) 565-574
2. Shioda T., and Nakayama E.E. Human genetic polymorphisms affecting HIV-1 diseases. Int J Hematol 84 (Jul 2006) 12-17 Review
3. Fowke K.R., Nagelkerke N.J., Kimani J., et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 348 (1996) 1347-1351
4. Lopalco L., Pastori C., Barassi C., et al. Heterogeneity in exposed uninfected individuals. J Biol Regul Homeost Agents 11 (1997) 27-31 Review
5. Liu R., Paxton W.A., Choe S., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
6. Geijtenbeek T.B., Kwon D.S., Torensma R., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-589
7. Barreiro L.B., Patin E., Nyrolles O., Cann H.M., Gicquel B., and Quintana-Murci. The heritage of pathogen pressure and ancient demography in the human innate immunity CD 209/CD 209 L region. Am J Hum Genet 77 (2005) 869-886
8. Wang Q., and Pang S. An intercellular adhesion molecule-3 (ICAM-3)-grabbing nonintegrin (DC-SIGN) efficiently blocks HIV viral budding. FASEB J 5 (Nov 2007)
9. Soilleux E.J., Barten R., and Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 from a cluster on 19p13. J Immunol 165 (2000) 2937-2942
10. Feinberg H., Guo Y., Mitchell D.A., Drickamer K., and Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 280 (2005) 1327-1335
11. Bashirova A.A., Geijtenbeek T.B., Van Duijnhoven G.C., et al. A dendritic cell specific intracellular adhesion molecule 3 grabbing nonintegrin (DC-SIGN) related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193 (2001) 671-678
12. Liu H., Hwangbo Y., Holte S., et al. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecular-3-grabbing nonintegrin in seronegative individual repeatedly exposed to HIV-1. J Infect Dis 190 (2004) 1055-1058
13. Wichukchinda N., Kitamura Y., Rojanawiwat A., et al. The polymorphism in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retrovir 23 (2007) 686-692
14. Zimmerman P.A., Buckler-White A., Alkhatib G., et al. Inherited resistant to HIV-1 conferred by an inactivating mutations in CC Chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background and quantified risk. Mol Med 3 (1997) 23-36